More from Renaissance Capital

Paratek Pharmaceuticals files for a $92 million IPO

By Renaissance Capital,  September 27, 2012, 06:01:30 PM EDT

Paratek Pharmaceuticals, which is focused on the discovery, development, and commercialization of innovative medicine, filed on Thursday with the SEC to raise up to $92 million in an initial public offering. The Boston, MA-based company, which was founded in 1996 and booked $76 million in sales for the 12 months ended 6/30/2012, plans to list on the NASDAQ under the symbol PRTK. UBS Investment Bank and Leerink Swann are the joint bookrunners on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: News Headlines, IPOs

Referenced Stocks:



Latest News Video

How to Pick Stocks in This Economic Environment
How to Pick Stocks in This Economic...
How To Grow Your Small Business
How To Grow Your Small Business     
Private Wealth Revives, Managers Face Higher Costs
Private Wealth Revives, Managers Fa...
Private Island on the Thames: $11.7 Million
Private Island on the Thames: $11.7...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.




Most Active by Volume:

Company Last Sale Change Net / %
S $ 7 0.32  4.37%
PFE $ 29.10 0.30  1.02%
BAC $ 13.19 0.08  0.60%
MU $ 13.97 0.22  1.60%
SIRI $ 3.37 0.03  0.88%
GE $ 23.98 0.35  1.44%
QQQ $ 72.76 0.82  1.11%
ELN $ 14.15 0.37  2.69%